Will Magenta Medical’s Elevate Disrupt the MCS Market?

Submitted by admin on August 8, 2024 - 10:17pm

Source:

Medical Devices and Diagnostics Industry

News Tags:

Headline:

snippet:

Magenta's Elevate aims to compete with Impella by offering a smaller insertion size and higher blood flow.
The company recently raised $105 million to advance Elevate through FDA approval and clinical trials.
Results from an early feasibility study for high-risk PCI patients were showcased at the 2023 TCT conference.

Search form